Keith McBurnett, PhD

Title(s)Professor Emeritus, Psychiatry
SchoolSchool of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
ORCID ORCID Icon0000-0001-7327-2435 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Latent Structure of Sluggish Cognitive Tempo and ADHD Symptoms
    NIH R21MH080810Aug 1, 2009 - May 31, 2012
    Role: Principal Investigator
    PSYCHOBIOLOGICAL STUDIES OF CHILD PSYCHOPATHOLOGY
    NIH K02MH001066Feb 1, 1993 - Aug 31, 1999
    Role: Principal Investigator
    CENTRAL AND PERIPHERAL ACTIONS OF AMPHETAMINE IN ADHD
    NIH R03MH048951Apr 1, 1991 - Mar 31, 1996
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Do Parents' ADHD Symptoms Affect Treatment for their Children? The Impact of Parental ADHD on Adherence to Behavioral Parent Training for Childhood ADHD. J Abnorm Child Psychol. 2020 11; 48(11):1425-1437. Friedman LM, Dvorsky MR, McBurnett K, Pfiffner LJ. PMID: 32813210; PMCID: PMC7567125.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Learning Disorder Confers Setting-Specific Treatment Resistance for Children with ADHD, Predominantly Inattentive Presentation. J Clin Child Adolesc Psychol. 2020 Nov-Dec; 49(6):854-867. Friedman LM, McBurnett K, Dvorsky MR, Hinshaw SP, Pfiffner LJ. PMID: 31433688; PMCID: PMC7032997.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Psychometric properties of a sluggish cognitive tempo scale in Japanese adults with and without ADHD. Atten Defic Hyperact Disord. 2019 Dec; 11(4):353-362. Takeda T, Burns GL, Jiang Y, Becker SP, McBurnett K. PMID: 30911898; PMCID: PMC6761053.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Long-Term Follow-up of Patients with Tourette's Syndrome. Mov Disord Clin Pract. 2019 Jan; 6(1):40-45. Lowe TL, Capriotti MR, McBurnett K. PMID: 30746414; PMCID: PMC6335508.
      View in: PubMed   Mentions: 6  
    5. Cost-Effectiveness of a Behavioral Psychosocial Treatment Integrated Across Home and School for Pediatric ADHD-Inattentive Type. Adm Policy Ment Health. 2018 09; 45(5):741-750. Tran JLA, Sheng R, Beaulieu A, Villodas M, McBurnett K, Pfiffner LJ, Wilson L. PMID: 29480503.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Distinguishing the efficacy and sedative effects of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol. 2019 03; 29(3):432-443. Huss M, McBurnett K, Cutler AJ, Hervás A, Bliss C, Gao J, Dirks B, Newcorn JH. PMID: 30064718.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Processing Speed Predicts Behavioral Treatment Outcomes in Children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Type. J Abnorm Child Psychol. 2018 05; 46(4):701-711. Adalio CJ, Owens EB, McBurnett K, Hinshaw SP, Pfiffner LJ. PMID: 28791531; PMCID: PMC5807232.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. Sustained Effects of Collaborative School-Home Intervention for Attention-Deficit/Hyperactivity Disorder Symptoms and Impairment. J Am Acad Child Adolesc Psychiatry. 2018 04; 57(4):245-251. Pfiffner LJ, Rooney ME, Jiang Y, Haack LM, Beaulieu A, McBurnett K. PMID: 29588050.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    9. Improved Parent Cognitions Relate to Immediate and Follow-Up Treatment Outcomes for Children With ADHD-Predominantly Inattentive Presentation. Behav Ther. 2018 07; 49(4):567-579. Jiang Y, Haack LM, Delucchi K, Rooney M, Hinshaw SP, McBurnett K, Pfiffner LJ. PMID: 29937258; PMCID: PMC6020154.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Parenting as a Mechanism of Change in Psychosocial Treatment for Youth with ADHD, Predominantly Inattentive Presentation. J Abnorm Child Psychol. 2017 Jul; 45(5):841-855. Haack LM, Villodas M, McBurnett K, Hinshaw S, Pfiffner LJ. PMID: 27628742; PMCID: PMC5352559.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    11. Atomoxetine-Related Change in Sluggish Cognitive Tempo Is Partially Independent of Change in Attention-Deficit/Hyperactivity Disorder Inattentive Symptoms. J Child Adolesc Psychopharmacol. 2017 02; 27(1):38-42. McBurnett K, Clemow D, Williams D, Villodas M, Wietecha L, Barkley R. PMID: 27845858.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    12. Parent Adherence in Two Behavioral Treatment Strategies for the Predominantly Inattentive Presentation of ADHD. J Clin Child Adolesc Psychol. 2018; 47(sup1):S233-S241. Rooney M, Hinshaw S, McBurnett K, Pfiffner L. PMID: 27808556.
      View in: PubMed   Mentions: 2     Fields:    
    13. Predictors of Response to Behavioral Treatments Among Children With ADHD-Inattentive Type. J Clin Child Adolesc Psychol. 2018; 47(sup1):S219-S232. Owens EB, Hinshaw SP, McBurnett K, Pfiffner L. PMID: 27806212; PMCID: PMC6093790.
      View in: PubMed   Mentions: 8     Fields:    
    14. Parental Cognitive Errors Mediate Parental Psychopathology and Ratings of Child Inattention. Fam Process. 2017 09; 56(3):716-733. Haack LM, Jiang Y, Delucchi K, Kaiser N, McBurnett K, Hinshaw S, Pfiffner L. PMID: 27663189; PMCID: PMC5365376.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Morning and Evening Effects of Guanfacine Extended Release Adjunctive to Psychostimulants in Pediatric ADHD. J Atten Disord. 2017 01; 21(2):110-119. Wilens TE, McBurnett K, Turnbow J, Rugino T, White C, Youcha S. PMID: 24071772.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    16. Effect of Atomoxetine Treatment on Reading and Phonological Skills in Children with Dyslexia or Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia in a Randomized, Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2017 02; 27(1):19-28. Shaywitz S, Shaywitz B, Wietecha L, Wigal S, McBurnett K, Williams D, Kronenberger WG, Hooper SR. PMID: 27410907; PMCID: PMC5327054.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. A Randomized Controlled Trial of a School-Implemented School-Home Intervention for Attention-Deficit/Hyperactivity Disorder Symptoms and Impairment. J Am Acad Child Adolesc Psychiatry. 2016 09; 55(9):762-70. Pfiffner LJ, Rooney M, Haack L, Villodas M, Delucchi K, McBurnett K. PMID: 27566117.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. The Internal, External, and Diagnostic Validity of Sluggish Cognitive Tempo: A Meta-Analysis and Critical Review. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):163-78. Becker SP, Leopold DR, Burns GL, Jarrett MA, Langberg JM, Marshall SA, McBurnett K, Waschbusch DA, Willcutt EG. PMID: 26903250; PMCID: PMC4764798.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    19. Sleep habits in children with attention-deficit/hyperactivity disorder predominantly inattentive type and associations with comorbid psychopathology symptoms. Sleep Med. 2016 05; 21:151-9. Becker SP, Pfiffner LJ, Stein MA, Burns GL, McBurnett K. PMID: 26922623; PMCID: PMC4889552.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Parenting Mediates Symptoms and Impairment in Children With ADHD-Inattentive Type. J Clin Child Adolesc Psychol. 2016; 45(2):155-66. Haack LM, Villodas MT, McBurnett K, Hinshaw S, Pfiffner LJ. PMID: 25411896; PMCID: PMC4465882.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    21. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2014 Oct; 53(10):1092-101. Cutler AJ, Brams M, Bukstein O, Mattingly G, McBurnett K, White C, Rubin J. PMID: 25245353.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. Additive effects of parent adherence on social and behavioral outcomes of a collaborative school-home behavioral intervention for ADHD. Child Psychiatry Hum Dev. 2014 Jun; 45(3):348-60. Villodas MT, McBurnett K, Kaiser N, Rooney M, Pfiffner LJ. PMID: 24043560; PMCID: PMC4808053.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2014 Jun; 24(5):245-52. Findling RL, McBurnett K, White C, Youcha S. PMID: 24945085; PMCID: PMC4064735.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    24. A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type. J Consult Clin Psychol. 2014 Dec; 82(6):1115-1127. Pfiffner LJ, Hinshaw SP, Owens E, Zalecki C, Kaiser NM, Villodas M, McBurnett K. PMID: 24865871; PMCID: PMC4244306.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    25. Bifactor latent structure of ADHD/ODD symptoms: predictions of dual-pathway/trait-impulsivity etiological models of ADHD. J Child Psychol Psychiatry. 2014 Apr; 55(4):393-401. Burns GL, de Moura MA, Beauchaine TP, McBurnett K. PMID: 24795957.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    26. Sluggish cognitive tempo in abnormal child psychology: an historical overview and introduction to the special section. J Abnorm Child Psychol. 2014 Jan; 42(1):1-6. Becker SP, Marshall SA, McBurnett K. PMID: 24272365.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    27. Structure and validity of sluggish cognitive tempo using an expanded item pool in children with attention-deficit/hyperactivity disorder. J Abnorm Child Psychol. 2014 Jan; 42(1):37-48. McBurnett K, Villodas M, Burns GL, Hinshaw SP, Beaulieu A, Pfiffner LJ. PMID: 24258302.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    28. Validity of the sluggish cognitive tempo symptom dimension in children: sluggish cognitive tempo and ADHD-inattention as distinct symptom dimensions. J Abnorm Child Psychol. 2014 Jan; 42(1):7-19. Lee S, Burns GL, Snell J, McBurnett K. PMID: 23325455.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    29. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol. 2013 Nov; 23(9):605-13. Wietecha L, Williams D, Shaywitz S, Shaywitz B, Hooper SR, Wigal SB, Dunn D, McBurnett K. PMID: 24206099; PMCID: PMC3842866.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    30. Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents. Clin Ther. 2013 Nov; 35(11):1778-93. Faraone SV, McBurnett K, Sallee FR, Steeber J, López FA. PMID: 24139092.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Negative social preference in relation to internalizing symptoms among children with ADHD predominantly inattentive type: girls fare worse than boys. J Clin Child Adolesc Psychol. 2013; 42(6):784-95. Becker SP, McBurnett K, Hinshaw SP, Pfiffner LJ. PMID: 23978167; PMCID: PMC3830725.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Pharmacotherapy of inattention and ADHD in adolescents. Adolesc Med State Art Rev. 2013 Aug; 24(2):391-405, viii. McBurnett K, Swetye M, Muhr H, Hendren RL. PMID: 24298754.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Educational outcomes of a collaborative school-home behavioral intervention for ADHD. Sch Psychol Q. 2013 Mar; 28(1):25-36. Pfiffner LJ, Villodas M, Kaiser N, Rooney M, McBurnett K. PMID: 23506023; PMCID: PMC4091627.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    34. Prevention of serious conduct problems in youth with attention deficit/hyperactivity disorder. Expert Rev Neurother. 2012 Oct; 12(10):1253-63. Villodas MT, Pfiffner LJ, McBurnett K. PMID: 23082741; PMCID: PMC4078981.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Validity of the sluggish cognitive tempo, inattention, and hyperactivity symptom dimensions: neuropsychological and psychosocial correlates. J Abnorm Child Psychol. 2012 Jul; 40(5):683-97. Bauermeister JJ, Barkley RA, Bauermeister JA, Martínez JV, McBurnett K. PMID: 22179974.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    36. New directions for therapeutics in ADHD. Neurotherapeutics. 2012 Jul; 9(3):487-9. Schweitzer JB, McBurnett K. PMID: 22855408; PMCID: PMC3441924.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes. J Abnorm Psychol. 2012 Nov; 121(4):991-1010. Willcutt EG, Nigg JT, Pennington BF, Solanto MV, Rohde LA, Tannock R, Loo SK, Carlson CL, McBurnett K, Lahey BB. PMID: 22612200; PMCID: PMC3622557.
      View in: PubMed   Mentions: 286     Fields:    Translation:Humans
    38. OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder. Expert Opin Pharmacother. 2011 Feb; 12(2):315-24. McBurnett K, Starr HL. PMID: 21226641.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    39. A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder. J Dev Behav Pediatr. 2010 Jun; 31(5):427-40. Connor DF, Steeber J, McBurnett K. PMID: 20535081.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    40. Child ADHD severity and positive and negative parenting as predictors of child social functioning: evaluation of three theoretical models. J Atten Disord. 2011 Apr; 15(3):193-203. Kaiser NM, McBurnett K, Pfiffner LJ. PMID: 20424006.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    41. Treatment of aggressive ADHD in children and adolescents: conceptualization and treatment of comorbid behavior disorders. Postgrad Med. 2009 Nov; 121(6):158-65. McBurnett K, Pfiffner LJ. PMID: 19940426.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Can executive functions explain the relationship between Attention Deficit Hyperactivity Disorder and social adjustment? J Abnorm Child Psychol. 2009 Jul; 37(5):679-91. Huang-Pollock CL, Mikami AY, Pfiffner L, McBurnett K. PMID: 19184400.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    43. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr. 2008 Dec; 13(12):1047-55. Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. PMID: 19179940.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    44. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008 Jan; 121(1):e73-84. Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N, SPD503 Study Group. PMID: 18166547.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    45. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol. 2007 Dec; 17(6):791-802. Arnold LE, Amato A, Bozzolo H, Hollway J, Cook A, Ramadan Y, Crowl L, Zhang D, Thompson S, Testa G, Kliewer V, Wigal T, McBurnett K, Manos M. PMID: 18315451.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. A randomized, controlled trial of integrated home-school behavioral treatment for ADHD, predominantly inattentive type. J Am Acad Child Adolesc Psychiatry. 2007 Aug; 46(8):1041-1050. Pfiffner LJ, Yee Mikami A, Huang-Pollock C, Easterlin B, Zalecki C, McBurnett K. PMID: 17667482.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    47. ADHD subtype differences in motivational responsivity but not inhibitory control: evidence from a reward-based variation of the stop signal paradigm. J Clin Child Adolesc Psychol. 2007 Apr-Jun; 36(2):127-36. Huang-Pollock CL, Mikami AY, Pfiffner L, McBurnett K. PMID: 17484686.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    48. Social skills differences among attention-deficit/hyperactivity disorder types in a chat room assessment task. J Abnorm Child Psychol. 2007 Aug; 35(4):509-21. Mikami AY, Huang-Pollock CL, Pfiffner LJ, McBurnett K, Hangai D. PMID: 17354064.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    49. Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2006 Oct; 34(5):725-35. Pfiffner LJ, McBurnett K. PMID: 17039405.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    50. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006 Jun; 16(3):351-6. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, Lerner M, Stein M. PMID: 16768642.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    51. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006 Jan; 160(1):82-90. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM. PMID: 16389216.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    52. ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2005 Oct; 44(10):1015-23. Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M. PMID: 16175106.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    53. Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2005 Oct; 33(5):551-63. Pfiffner LJ, McBurnett K, Rathouz PJ, Judice S. PMID: 16195950.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    54. Mood and hormone responses to psychological challenge in adolescent males with conduct problems. Biol Psychiatry. 2005 May 15; 57(10):1109-16. McBurnett K, Raine A, Stouthamer-Loeber M, Loeber R, Kumar AM, Kumar M, Lahey BB. PMID: 15866550.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    55. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K). Yonsei Med J. 2004 Feb 29; 45(1):81-9. Kim YS, Cheon KA, Kim BN, Chang SA, Yoo HJ, Kim JW, Cho SC, Seo DH, Bae MO, So YK, Noh JS, Koh YJ, McBurnett K, Leventhal B. PMID: 15004873.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    56. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. PMID: 12649629.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    57. Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys. J Abnorm Psychol. 2002 Nov; 111(4):556-67. Lahey BB, Loeber R, Burke J, Rathouz PJ, McBurnett K. PMID: 12428769.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    58. Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct; 108(4):883-92. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G. PMID: 11581440.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansCTClinical Trials
    59. Antisocial personality, substance abuse, and exposure to parental violence in males referred for domestic violence. Violence Vict. 2001 Oct; 16(5):491-506. McBurnett K, Kerckhoff C, Capasso L, Pfiffner LJ, Rathouz PJ, McCord M, Harris SM. PMID: 11688925.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Father absence and familial antisocial characteristics. J Abnorm Child Psychol. 2001 Oct; 29(5):357-67. Pfiffner LJ, McBurnett K, Rathouz PJ. PMID: 11695539.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    61. Symptom properties as a function of ADHD type: an argument for continued study of sluggish cognitive tempo. J Abnorm Child Psychol. 2001 Jun; 29(3):207-13. McBurnett K, Pfiffner LJ, Frick PJ. PMID: 11411783.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    62. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol. 2000 Dec; 28(6):507-25. Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, Simpson S, Shapiro C, Bukstein O, Baron-Myak C, McBurnett K. PMID: 11104314.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    63. Interventions to enhance social competence. Child Adolesc Psychiatr Clin N Am. 2000 Jul; 9(3):689-709, x. Pfiffner LJ, Calzada E, McBurnett K. PMID: 10944663.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    64. Evaluation of the validity of the Wechsler Intelligence Scale for Children--Third Edition comprehension and picture arrangement subtests as measures of social intelligence. Psychol Assess. 2000 Mar; 12(1):97-101. Beebe DW, Pfiffner LJ, McBurnett K. PMID: 10752368.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000 Mar; 3(1):37-60. Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. PMID: 11228766.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    66. Low salivary cortisol and persistent aggression in boys referred for disruptive behavior. Arch Gen Psychiatry. 2000 Jan; 57(1):38-43. McBurnett K, Lahey BB, Rathouz PJ, Loeber R. PMID: 10632231.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    67. Association of parental psychopathology to the comorbid disorders of boys with attention deficit-hyperactivity disorder. J Consult Clin Psychol. 1999 Dec; 67(6):881-893. Pfiffner LJ, McBurnett K, Lahey BB, Loeber R, Green S, Frick PJ, Rathouz PJ. PMID: 10596510.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    68. Annotation: the development of antisocial behavior: an integrative causal model. J Child Psychol Psychiatry. 1999 Jul; 40(5):669-82. Lahey BB, Waldman ID, McBurnett K. PMID: 10433402.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    69. Experimental cross-validation of DSM-IV types of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999 Jan; 38(1):17-24. McBurnett K, Pfiffner LJ, Willcutt E, Tamm L, Lerner M, Ottolini YL, Furman MB. PMID: 9893412.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    70. Validity of DSM-IV subtypes of conduct disorder based on age of onset. J Am Acad Child Adolesc Psychiatry. 1998 Apr; 37(4):435-42. Lahey BB, Loeber R, Quay HC, Applegate B, Shaffer D, Waldman I, Hart EL, McBurnett K, Frick PJ, Jensen PS, Dulcan MK, Canino G, Bird HR. PMID: 9549965.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    71. Social skills training with parent generalization: treatment effects for children with attention deficit disorder. J Consult Clin Psychol. 1997 Oct; 65(5):749-57. Pfiffner LJ, McBurnett K. PMID: 9337494.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCTClinical Trials
    72. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry. 1997 Sep; 36(9):1211-21. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, McBurnett K, Newcorn JH, Kerdyk L, Garfinkel B, Waldman I, Shaffer D. PMID: 9291722.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCTClinical Trials
    73. Aggressive symptoms and salivary cortisol in clinic-referred boys with conduct disorder. Ann N Y Acad Sci. 1996 Sep 20; 794:169-78. McBurnett K, Lahey BB, Capasso L, Loeber R. PMID: 8853601.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    74. Psychopathy and conduct problems in children. J Abnorm Psychol. 1994 Nov; 103(4):700-7. Frick PJ, O'Brien BS, Wootton JM, McBurnett K. PMID: 7822571.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    75. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994 Nov; 151(11):1673-85. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Barkley RA, Newcorn J, Jensen P, Richters J, et al. PMID: 7943460.
      View in: PubMed   Mentions: 208     Fields:    Translation:Humans
    76. DSM-IV field trials for oppositional defiant disorder and conduct disorder in children and adolescents. Am J Psychiatry. 1994 Aug; 151(8):1163-71. Lahey BB, Applegate B, Barkley RA, Garfinkel B, McBurnett K, Kerdyk L, Greenhill L, Hynd GW, Frick PJ, Newcorn J, et al. PMID: 8037251.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    77. Psychophysiological and neuroendocrine correlates of conduct disorder and antisocial behavior in children and adolescents. Prog Exp Pers Psychopathol Res. 1994; 199-231. McBurnett K, Lahey BB. PMID: 8044204.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. ADHD and LD. J Learn Disabil. 1991 May; 24(5):258-60. McBurnett K, Pfiffner LJ. PMID: 2045720.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Effects of stimulant medication on learning in children with ADHD. J Learn Disabil. 1991 Apr; 24(4):219-30, 255. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G. PMID: 1875157.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    80. Anxiety, inhibition, and conduct disorder in children: I. Relations to social impairment. J Am Acad Child Adolesc Psychiatry. 1991 Mar; 30(2):187-91. Walker JL, Lahey BB, Russo MF, Frick PJ, Christ MA, McBurnett K, Loeber R, Stouthamer-Loeber M, Green SM. PMID: 2016220.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    81. Anxiety, inhibition, and conduct disorder in children: II. Relation to salivary cortisol. J Am Acad Child Adolesc Psychiatry. 1991 Mar; 30(2):192-6. McBurnett K, Lahey BB, Frick PJ, Risch C, Loeber R, Hart EL, Christ MA, Hanson KS. PMID: 2016221.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    82. Serious conduct problems in the children of adolescent mothers: disentangling confounded correlations. J Consult Clin Psychol. 1990 Dec; 58(6):840-4. Christ MA, Lahey BB, Frick PJ, Russo MF, McBurnett K, Loeber R, Stouthamer-Loeber M, Green S. PMID: 2292634.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. Methylphenidate and baseball playing in ADHD children: who's on first? J Consult Clin Psychol. 1990 Feb; 58(1):130-133. Pelham WE, McBurnett K, Harper GW, Milich R, Murphy DA, Clinton J, Thiele C. PMID: 2319047.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    84. Conduct disorder: parsing the confounded relation to parental divorce and antisocial personality. J Abnorm Psychol. 1988 Aug; 97(3):334-7. Lahey BB, Hartdagen SE, Frick PJ, McBurnett K, Connor R, Hynd GW. PMID: 3192827.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    85. Psychopathology in the parents of children with conduct disorder and hyperactivity. J Am Acad Child Adolesc Psychiatry. 1988 Mar; 27(2):163-70. Lahey BB, Piacentini JC, McBurnett K, Stone P, Hartdagen S, Hynd G. PMID: 3360717.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans